Program Information
Voxel-Level Analysis of Adverse Treatment Response in Pediatric Patients Treated for Ependymoma with Passive Scattering Proton Therapy
C Peeler1,2*, D Mirkovic1 , U Titt1 , D Grosshans1 , R Mohan1 , (1) The University of Texas MD Anderson Cancer Center, Houston, TX, (2) The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX
Presentations
WE-FG-202-9 (Wednesday, August 3, 2016) 1:45 PM - 3:45 PM Room: 202
Purpose: We identified patients treated for ependymoma with passive scattering proton therapy who subsequently developed treatment-related imaging changes on MRI. We sought to determine if there is any spatial correlation between imaged response, dose, and LET.
Methods: A group of 14 patients treated for ependymoma were identified as having post-treatment MR imaging changes observable as T2-FLAIR hyperintensity with or without enhancement on T1 post-contrast sequences. MR images were registered with treatment planning CT images and regions of treatment-related change contoured by a practicing radiation oncologist. The contoured regions were identified as response with voxels represented as 1 while voxels within the brain outside of the response region were represented as 0. An in-house Monte Carlo system was used to recalculate treatment plans to obtain dose and LET information. Voxels were binned according to LET values in 0.3 keV μm⁻¹ bins. Dose and corresponding response value (0 or 1) for each voxel for a given LET bin were then plotted and fit with the Lyman-Kutcher-Burman dose response model to determine TD₅₀ and m parameters for each LET value. Response parameters from all patients were then collated, and linear fits of the data were performed.
Results: The response parameters TD50 and m both show trends with LET. Outliers were observed due to low numbers of response voxels in some cases. TD₅₀ values decreased with LET while m increased with LET. The former result would indicate that for higher LET values, the dose is more effective, which is consistent with relative biological effectiveness (RBE) models for proton therapy.
Conclusion: A novel method of voxel-level analysis of image biomarker-based adverse patient treatment response in proton therapy according to dose and LET has been presented. Fitted TD₅₀ values show a decreasing trend with LET supporting the typical models of proton RBE.
Funding Support, Disclosures, and Conflict of Interest: Funding provided by NIH Program Project Grant 2U19CA021239-35.
Contact Email: